A Bite of Hope in Dark Chocolate

Reading time: 5 minutes Sandhyaa Venkatachalam Who doesn’t love dark chocolate? A moment of pure bliss in every square… a deep, complex flavor in every bite… a luxurious treat that dances between bitter and sweet… dark chocolate is a true celebration of indulgence. What’s more tempting is the abundant dose of health benefits that dark... Continue Reading →

Under the brain tumor spell

Reading time: 5 minutes Mariella Careaga Glioblastoma is a highly aggressive form of cancer that accounts for nearly half of all primary malignant brain tumors in adults (1). Patients diagnosed with this deadly brain cancer have an average survival rate of only 8 months, and it is estimated that glioblastoma claims the lives of more... Continue Reading →

Double Trouble for Cancer: The Rise of Bispecific Antibodies

Reading time: 5 minutes Dolores Mruk, PhD Cancer treatments have come a long way since the early 1900s, evolving from chemotherapy and radiotherapy to more targeted interventions. One promising approach involves the use of bispecific antibodies (bsAbs)—engineered molecules that help in fighting cancer. Today, these immunotherapies are being studied across different malignancies, with a particular... Continue Reading →

Can overstimulation of oncogenic signaling of cancer cells be a potential therapeutic strategy?

Reading time: 6 minutes Colin Ong Oncogenic signaling is a key characteristic of cancer cells Cancer cells, unlike normal cells, exhibit aberrant oncogenic signaling. This aberrant signaling, which is continuously turned on, facilitates the survival and proliferation of cancer cells as well as other hallmarks of cancer1. The term “oncogenic”, an adjective derived from the... Continue Reading →

Advancing CAR-T Cell Therapy: New Innovations in Outpatient Administration and Management

Reading time: 6 minutes Nicole Bowens Recent advancements within the past decade are making cancer treatments more effective and accessible, revolutionizing the way care is delivered and offering renewed hope to patients. These advancements have been made possible in part by personalized therapies that are tailored for individual patients.  In one newly developed personalized therapy,... Continue Reading →

To sync or not to sync: Cancer’s complicated relationship with our internal clocks

Reading time: 5 minutes Andrea Lius For several decades, scientists have observed that disruptions to the body’s internal clock, also known as the circadian rhythm, can promote cancer development and progression.1 They also found that many fast-growing cancers have circadian rhythms that are desynchronized from healthy cells. However, glioblastoma (GBM), a deadly and aggressive type... Continue Reading →

The Obesity Paradox

Reading time: 8 minutes Nicholas A. Egan Obesity is a rising global health epidemic, with the number of obese adults doubling since the 1990s and the number of adolescents living with obesity quadrupling. This amounts to one in every eight people in the world living with obesity. Obesity comes with myriad other health issues. Specifically,... Continue Reading →

Vorasidenib: A case study in bench-to-bedside translational research

Reading time: 6 minutes Spencer Maingi Identifying IDH mutations and their function In 2008, researchers studying brain tumors discovered something surprising. Patients with “secondary glioblastoma”, a uniformly lethal cancer that arises from a prior, less aggressive brain tumor (“low-grade glioma”), frequently had mutations in their tumor in the gene isocitrate dehydrogenase 1 (IDH1).1 Even more... Continue Reading →

Hepatic Arterial Infusion Chemotherapy

Reading Time: 4 minutes Chris Wang The liver is a uniquely important organ in your body. It filters all of your blood, produces bile to digest foods/carry away waste, and can even regenerate even after 90% has been removed. Unfortunately, the liver is also an organ where many cancers metastasize to. Colorectal cancer in particular... Continue Reading →

Promising trials: Lorlatinib for NSCLC

Reading time: 4 minutes Karli Norville In 2021, lung cancer was ranked as the number one cause of cancer deaths in the United States (1). The American Cancer Society reports that the 5-year survival rate of all Non-Small Cell Lung Cancer (NSCLC) patients is 26% (2). A recent study of the cancer drug Lorlatinib announced... Continue Reading →

Glioblastoma: 100 Years of Failure

Reading time: 7 minutes Shan Grewal Glioblastoma multiforme (GBM) is one of the worst diagnoses a patient can receive today. The median survival of this cancer is just under 15 months, meaning half of patients with GBM will pass away within 1.5 years. Only 4% of patients reach the 5-year mark.1 GBM has left an... Continue Reading →

Integrating Mental Health into Oncology: Assessing Depression Among Cancer Patients Using the Beck Depression Inventory-II

Reading time: 3 minutes Maya Razmi Understanding depression in cancer patients is crucial for holistic care. This study highlights the prevalence of depression using the Beck Depression Inventory-II, emphasizing the need for integrated mental health support in oncology. Oftentimes, when we think of oncology research, we think of novel diagnostics and therapeutics. However, cancer is... Continue Reading →

From Algorithms to Articles: AI in Scientific and Medical Writing and Application

Reading time: 5 minutes Keighley Reisenauer, Ph.D Chat Generative Pre‐trained Transformer (ChatGPT; OpenAI, San Francisco, CA) and other artificial intelligence (AI)-based generative software have taken hold within social media and creative spheres, to both the delight and annoyance of the users within those spaces. Initially, outputs were flawed or, in some cases, completely incorrect, leading... Continue Reading →

Putting a Backpack on Cells to Treat Cancer

Reading time: 4 minutes Colette Bilynsky The wonders of cellular therapies and immunotherapies have been often discussed here on Oncobites. But one of the challenges here is that these strategies are dependent on immune cells' ability to reach tumors and still function. However, tumors will often try to evade and stop the immune system from... Continue Reading →

Antibiotics in Cancer Treatment: Unraveling the Unseen Risks

Reading time: 3 minutes Yonika Larasati Since the advent of antibiotics more than one century ago, this class of drugs has tremendously changed humanity. In addition to treating bacteria-caused infectious diseases, antibiotics enable modern medical procedures, such as open-heart surgery and organ transplantation. Antibiotics are also essential for cancer patients. Cancer patients often face an... Continue Reading →

Create a website or blog at WordPress.com

Up ↑